Fentanyl Transdermal Patches Market

Global Fentanyl Transdermal Patches Market Size, Share and Trends Analysis Report, By Type (12 mcg/h, 25 mcg/h, 50 mcg/h, 75 mcg/h, and 100 mcg/h), By Application (Musculoskeletal Pain, Auto-immune Disease, Post-operative Pain, Cancer Pain, and Others), Forecast (2022-2028)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2026145 | Category : Pharmaceuticals | Delivery Format: /

The global fentanyl transdermal patches market is anticipated to grow at a significant CAGR 3.2% during the forecast period (2022-2028). Fentanyl transdermal patch is used for the treatment of chronic pain in opioid-tolerant people. These patches are administrated when an opioid analgesic is needed to be used for an extended period. The major factor driving the demand for fentanyl transdermal patches is the increasing prevalence of chronic pain anmcancer pain across the globe. 

Moreover, the market is also growing due to the rising prescription rate for fentanyl patches coupled with the increasing demand for OTC non-opioid or pain medicines globally. Additionally, these patches are strong opioid agent which is considered to be 100 times more potent than morphine. Further, it continuously supplies drugs to the skin surface and enables drugs to circulate in the body for several days. However, the market growth is hampered due to the side effects related to these patches such as serious breathing problems, severely low blood pressure, adrenal insufficiency and androgen deficiency among others. 

Moreover, North America is expected to hold a prominent share in the market owing to the rising prevalence of cancer in the region. Additionally, transdermal patches support to deliver pain management drugs at a fixed proportionate rate to attain either a local or a systemic effect in cancer. Furthermore, the market is also growing due to the increasing geriatric population across the globe. Some major players in the market include Mylan N.V., and Novartis International AG, among others. 

Market Coverage

The market number available for – 2021-2028

Base year- 2021

Forecast period- 2022-2028

Segment Covered- 

o By Type

o By Application

Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape- Mylan N.V., and Novartis International AG, among others 

Key questions addressed by the report

What is the market growth rate?

Which segment and region dominate the market in the base year?

Which segment and region will project the fastest growth in the market?

How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?

How players are addressing challenges to sustain growth?

Where is the investment opportunity?

Global Fentanyl Transdermal Patches Market Report by Segment

By Type

12 mcg/h

25 mcg/h

50 mcg/h

75 mcg/h

100 mcg/h

By Application 

Musculoskeletal Pain

Auto-Immune Disease

Post-Operative Pain

Cancer Pain

Others

Global Fentanyl Transdermal Patches Market Report by Region

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe 

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific 

Rest of the World

Latin America 

Middle East & Africa